RU2015101485A - Композиция и состав для наружного лечения воспаления и поражения тканей - Google Patents
Композиция и состав для наружного лечения воспаления и поражения тканей Download PDFInfo
- Publication number
- RU2015101485A RU2015101485A RU2015101485A RU2015101485A RU2015101485A RU 2015101485 A RU2015101485 A RU 2015101485A RU 2015101485 A RU2015101485 A RU 2015101485A RU 2015101485 A RU2015101485 A RU 2015101485A RU 2015101485 A RU2015101485 A RU 2015101485A
- Authority
- RU
- Russia
- Prior art keywords
- composition according
- paragraphs
- treatment
- inflammatory diseases
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 35
- 206010061218 Inflammation Diseases 0.000 title claims abstract 3
- 230000004054 inflammatory process Effects 0.000 title claims abstract 3
- 208000027866 inflammatory disease Diseases 0.000 claims abstract 12
- 230000007850 degeneration Effects 0.000 claims abstract 6
- 210000001519 tissue Anatomy 0.000 claims abstract 5
- 230000000451 tissue damage Effects 0.000 claims abstract 5
- 231100000827 tissue damage Toxicity 0.000 claims abstract 5
- 102000002322 Egg Proteins Human genes 0.000 claims abstract 4
- 108010000912 Egg Proteins Proteins 0.000 claims abstract 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract 4
- 230000001684 chronic effect Effects 0.000 claims abstract 4
- 229940079593 drug Drugs 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 4
- 201000008482 osteoarthritis Diseases 0.000 claims abstract 4
- 241001465754 Metazoa Species 0.000 claims abstract 3
- -1 proteolytics Substances 0.000 claims abstract 3
- 208000023275 Autoimmune disease Diseases 0.000 claims abstract 2
- 239000003242 anti bacterial agent Substances 0.000 claims abstract 2
- 229940088710 antibiotic agent Drugs 0.000 claims abstract 2
- 239000003146 anticoagulant agent Substances 0.000 claims abstract 2
- 229940127219 anticoagulant drug Drugs 0.000 claims abstract 2
- 229940121375 antifungal agent Drugs 0.000 claims abstract 2
- 239000003429 antifungal agent Substances 0.000 claims abstract 2
- 239000003963 antioxidant agent Substances 0.000 claims abstract 2
- 230000003412 degenerative effect Effects 0.000 claims abstract 2
- 230000002538 fungal effect Effects 0.000 claims abstract 2
- 230000002757 inflammatory effect Effects 0.000 claims abstract 2
- 230000003902 lesion Effects 0.000 claims abstract 2
- 208000004396 mastitis Diseases 0.000 claims abstract 2
- 229940035363 muscle relaxants Drugs 0.000 claims abstract 2
- 239000003158 myorelaxant agent Substances 0.000 claims abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims abstract 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims abstract 2
- 230000007170 pathology Effects 0.000 claims abstract 2
- 102000004169 proteins and genes Human genes 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract 2
- 230000002797 proteolythic effect Effects 0.000 claims abstract 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims abstract 2
- 239000011780 sodium chloride Substances 0.000 claims abstract 2
- 230000003637 steroidlike Effects 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims abstract 2
- 230000003612 virological effect Effects 0.000 claims abstract 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims 2
- 241001135917 Vitellaria paradoxa Species 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 229940057910 shea butter Drugs 0.000 claims 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims 1
- 210000000991 chicken egg Anatomy 0.000 claims 1
- 239000004927 clay Substances 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 229960005150 glycerol Drugs 0.000 claims 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 claims 1
- 229910000271 hectorite Inorganic materials 0.000 claims 1
- 229940057995 liquid paraffin Drugs 0.000 claims 1
- 229960004063 propylene glycol Drugs 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 229940005550 sodium alginate Drugs 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Pregnancy & Childbirth (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2012A001076 | 2012-06-20 | ||
| IT001076A ITMI20121076A1 (it) | 2012-06-20 | 2012-06-20 | Composizione per uso locale nel trattamento del danno tissutale |
| PCT/IB2013/055066 WO2013190496A2 (en) | 2012-06-20 | 2013-06-20 | Composition and formulation for topical treatment of inflammation and tissue damage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2015101485A true RU2015101485A (ru) | 2016-08-10 |
Family
ID=46466706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015101485A RU2015101485A (ru) | 2012-06-20 | 2013-06-20 | Композиция и состав для наружного лечения воспаления и поражения тканей |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20150320838A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2863928A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2015520223A (cg-RX-API-DMAC7.html) |
| CN (1) | CN104640552A (cg-RX-API-DMAC7.html) |
| IN (1) | IN2015KN00091A (cg-RX-API-DMAC7.html) |
| IT (1) | ITMI20121076A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2015101485A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013190496A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101979358B1 (ko) * | 2017-01-03 | 2019-05-15 | 서울대학교산학협력단 | 소 유방염 치료제 조성물 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5897880A (en) * | 1995-09-29 | 1999-04-27 | Lam Pharmaceuticals, Llc. | Topical drug preparations |
| CN1178671C (zh) | 1996-03-26 | 2004-12-08 | Dcv公司 | 蛋抗炎成分、分离方法和用途 |
| WO2000043019A2 (en) * | 1999-01-19 | 2000-07-27 | Dcv Inc | Egg anti-inflammatory composition and method of treating and preventing inflammation |
| CA2384246A1 (en) * | 1999-09-14 | 2001-03-22 | Orn Adalsteinsson | Glucosamine and egg reducing inflammation |
| US6706267B1 (en) * | 1999-09-14 | 2004-03-16 | Arkion Life Sciences Llc | Glucosamine and egg for reducing inflammation |
| AU2001260794A1 (en) * | 2000-05-23 | 2001-12-03 | N.V. Nutricia | Use of egg white and egg white fractions for tissue regeneration |
| FR2810550B1 (fr) | 2000-06-27 | 2004-10-08 | Medibrevex | Nouvelle formes galeiques solubles d'oeufs de caille a usage medicamenteux pour lavage oculaire et nasale et leurs procedes de fabrication |
| RU2191551C1 (ru) | 2001-07-05 | 2002-10-27 | Волков Александр Григорьевич | Способ лечения неосложненных фронтитов |
| JP5184726B2 (ja) * | 2001-10-16 | 2013-04-17 | 帝國製薬株式会社 | グルコサミン含有パップ剤 |
| US20030125303A1 (en) * | 2001-12-28 | 2003-07-03 | Andrew Kucharchuk | Transdermal formulation for repair and maintenance of connective tissue |
| IL148292A (en) * | 2002-02-21 | 2008-08-07 | Shai Yarkoni | Stable preparations of lupoginone and other quinazolinone derivatives |
| JP4256125B2 (ja) * | 2002-08-05 | 2009-04-22 | ロート製薬株式会社 | 外用組成物 |
| US20050053564A1 (en) * | 2003-09-04 | 2005-03-10 | Chaim Lieberman | Use a plant extract to enhance hair growth and hair restoration for damaged hair |
| WO2005097069A1 (en) * | 2004-03-26 | 2005-10-20 | Stiefel Laboratories, Inc. | Topical skin protectant cosmetic compositions |
| US20060110415A1 (en) * | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
| EP2094277A4 (en) * | 2006-10-20 | 2010-01-20 | Kim Soo Youl | COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS WITH GLUCOSAMINE AND ITS DERIVATIVES AND METHOD FOR THE TREATMENT OF ATOPIC DERMATITIS THEREWITH |
| JP5158436B2 (ja) * | 2008-09-18 | 2013-03-06 | 国立大学法人 鹿児島大学 | 抗菌剤およびその製造方法、化粧料ならびに医薬品 |
-
2012
- 2012-06-20 IT IT001076A patent/ITMI20121076A1/it unknown
-
2013
- 2013-06-20 CN CN201380043623.0A patent/CN104640552A/zh active Pending
- 2013-06-20 RU RU2015101485A patent/RU2015101485A/ru not_active Application Discontinuation
- 2013-06-20 EP EP13759577.3A patent/EP2863928A2/en not_active Withdrawn
- 2013-06-20 JP JP2015517910A patent/JP2015520223A/ja active Pending
- 2013-06-20 IN IN91KON2015 patent/IN2015KN00091A/en unknown
- 2013-06-20 WO PCT/IB2013/055066 patent/WO2013190496A2/en not_active Ceased
- 2013-06-20 US US14/409,130 patent/US20150320838A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI20121076A1 (it) | 2013-12-21 |
| CN104640552A (zh) | 2015-05-20 |
| US20150320838A1 (en) | 2015-11-12 |
| WO2013190496A2 (en) | 2013-12-27 |
| JP2015520223A (ja) | 2015-07-16 |
| EP2863928A2 (en) | 2015-04-29 |
| IN2015KN00091A (cg-RX-API-DMAC7.html) | 2015-07-31 |
| WO2013190496A3 (en) | 2014-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016130098A (ru) | Композиции в виде геля для местного применения, включающие полимер поликапролактон, и способы повышения эффективности местного применения полезного средства | |
| MX2024001218A (es) | Preparacion y almacenamiento de formulaciones liposomales de arn adecuadas para terapia. | |
| CL2013001567A1 (es) | Combinaciones de principios activos que comprenden piridiletilbenzamidas ; procedimiento para combatir plagas animales; uso de la combinación para tratar semillas. | |
| BR112013010853A2 (pt) | "agentes citotóxicos compreendendo derivados de ansamitocina, composição farmacêutica e uso destes" | |
| EA201890516A1 (ru) | Клинические композиции | |
| WO2017100700A3 (en) | Peptides for renal therapy | |
| BR112015006828A8 (pt) | composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; uso do composto; e método para modular a atividade de uma proteína ire1 | |
| MX361590B (es) | Suministro topico de composiciones para la piel que tienen ph bajo. | |
| WO2014165607A3 (en) | Aromatic-cationic peptide formulations, compositions and methods of use | |
| RU2016129490A (ru) | Композиции в виде геля для местного применения, включающие сополимер моностеароил-глицерина и сукцината, и способы повышения эффективности местного применения полезного средства | |
| CL2018000712A1 (es) | Adyuvantes mejorados para productos agroquímicos | |
| BR112014008700A2 (pt) | composições úteis no tratamento de nefropatia e processos para preparação das mesmas | |
| CL2008001640A1 (es) | Uso de hidroxiprolina para preparar una composicion de alemento destinada a promover el crecimiento de un animal, como peces, aves y mamiferos. | |
| CL2008000079A1 (es) | Compuestos espirociclicos derivados del acido tetronico; procedimiento de preparacion de dichos compuestos; uso de composiciones; pesticidas; procedimiento para combatir plagas de animales; uso de dichos compuestos; y procedimiento para preparar pest | |
| RU2016135431A (ru) | Композиция для местного лечения ран | |
| MX377300B (es) | Terapia con células madre en patologías endometriales. | |
| EA201490032A1 (ru) | Лиофилизированные препараты fgf-18 | |
| WO2016210376A3 (en) | Therapeutic peptides and methods of use thereof | |
| EA201390077A1 (ru) | Белок-переносчик глюкозинолатов и его применения | |
| RU2018111036A (ru) | Композиции, содержащие экстракт эхинацеи и производные соединения линолевой кислоты | |
| RU2016148689A (ru) | Комбинация тетрапептида и эфира глицерина для лечения андрогенной алопеции | |
| RU2015101485A (ru) | Композиция и состав для наружного лечения воспаления и поражения тканей | |
| BR112017017643A2 (pt) | formulação farmacêutica tópica | |
| BR112013022557A2 (pt) | ligantes de peptídeo composições de polipeptídeo e métodos para uso dos mesmos | |
| RU2015154451A (ru) | Композиция для повышения качества спермы у субъекта мужского пола |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20170807 |